AbbVie Inc (LTS:0QCV)
$ 174.92 -0.4 (-0.23%) Market Cap: 302.34 Bil Enterprise Value: 366.13 Bil PE Ratio: 60.57 PB Ratio: 51.09 GF Score: 86/100

Abbvie Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 03:00PM GMT
Release Date Price: $76
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

Great. So good morning, everyone. This is David Risinger from Morgan Stanley. I cover both major and specialty pharmaceuticals, and it's my pleasure to host this session with the AbbVie leadership team. Please note that we do need to refer you to disclaimers, specifically the Morgan Stanley research site, www.morganstanley.com/researchdisclosures. And note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. It's not for members of the press. So if you're a member of the press, please disconnect and reach out separately. And if you have any questions, please reach out to your Morgan Stanley representative.

So I wanted to thank the leadership team from AbbVie for joining. It's my pleasure to welcome Chairman and CEO, Rick Gonzalez, Vice Chairman and President, Mike Severino; and Executive Vice President and CFO, Rob Michael.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot